Ramiro Borges Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramiro Borges Rodrigues has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Ana Claudia Mércio Loredo Souza
Pediatric Bipolar Disorder Outpatient Program (ProCAB), Universidade Federal do Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil
1 shared publicationAndre de Moura Kohmann
Pediatric Bipolar Disorder Outpatient Program (ProCAB), Universidade Federal do Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil
1 shared publicationBianca Wollenhaupt de Aguiar
Bipolar Disorder Unit, Molecular Psychiatry Unit and National Institute for Translational Medicine, CNPq., 90035-903 Porto Alegre, RS, Brazil
1 shared publication- Cristian Zeni
UTHealth, Houston, TX USA
1 shared publication Flavio Kapczinski
Federal University, UFRGS, 90035-903 Porto Alegre, RS, Brazil
1 shared publicationJuliana Basso Brun
Pediatric Bipolar Disorder Outpatient Program (ProCAB), Universidade Federal do Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil
1 shared publication
Latest Publications
- Open Access
- 13 May 2015
- Published by Hindawi Limited in Neural Plasticity
- Vol. 2015, 1-7
Correlation between Peripheral Levels of Brain-Derived Neurotrophic Factor and Hippocampal Volume in Children and Adolescents with Bipolar Disorder
Pediatric bipolar disorder (PBD) is a serious mental disorder that affects the development and emotional growth of affected patients. The brain derived neurotrophic factor (BDNF) is recognized as one of the possible markers of the framework and its evolution. Abnormalities in BDNF signaling in the hippocampus could explain the cognitive decline seen in patients with TB. Our aim with this study was to evaluate possible changes in hippocampal volume in children and adolescents with BD and associate them to serum BDNF. Subjects included 30 patients aged seven to seventeen years from the ProCAB (Program for Children and Adolescents with Bipolar Disorder). We observed mean right and left hippocampal volumes of 41910.55 and 41747.96 mm3, respectively. No statistically significant correlations between peripheral BDNF levels and hippocampal volumes were found. We believe that the lack of correlation observed in this study is due to the short time of evolution of BD in children and adolescents. Besides studies with larger sample sizes to confirm the present findings and longitudinal assessments, addressing brain development versus a control group and including drug-naive patients in different mood states may help clarify the role of BDNF in the brain changes consequent upon BD.
- 13 May 2015
- Published by Hindawi Limited in Neural Plasticity
- Vol. 2015, 1-7
Open AccessCorrelation between Peripheral Levels of Brain-Derived Neurotrophic Factor and Hippocampal Volume in Children and Adolescents with Bipolar Disorder
Pediatric bipolar disorder (PBD) is a serious mental disorder that affects the development and emotional growth of affected patients. The brain derived neurotrophic factor (BDNF) is recognized as one of the possible markers of the framework and its evolution. Abnormalities in BDNF signaling in the hippocampus could explain the cognitive decline seen in patients with TB. Our aim with this study was to evaluate possible changes in hippocampal volume in children and adolescents with BD and associate them to serum BDNF. Subjects included 30 patients aged seven to seventeen years from the ProCAB (Program for Children and Adolescents with Bipolar Disorder). We observed mean right and left hippocampal volumes of 41910.55 and 41747.96 mm3, respectively. No statistically significant correlations between peripheral BDNF levels and hippocampal volumes were found. We believe that the lack of correlation observed in this study is due to the short time of evolution of BD in children and adolescents. Besides studies with larger sample sizes to confirm the present findings and longitudinal assessments, addressing brain development versus a control group and including drug-naive patients in different mood states may help clarify the role of BDNF in the brain changes consequent upon BD.